Tilorone (2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one dihydrochloride) was administered to CD-1 or C57L × A F1 mice alone or with allogeneic leukemia L1210 cells. Tilorone given alone elicited thymus-dependent lymphocytes in the spleen causing cell-mediated immunity (CMI) comparable to that of lymphocytes exposed to 5 × 104 L1210 cells. This occurred whether Tilorone was administered p.o. or i.p. When administered 24 hr after L1210 cells, an adjuvant effect of Tilorone upon CMI was not demonstrable unless glass-adherent spleen cells were removed before in vitro assay. In groups given Tilorone or L1210 alone, CMI was unchanged after removal of adherent cells. Release of lymphoycte-activating factor by the spleen was unaffected by Tilorone. It is suggested that Tilorone has a moderate direct stimulatory effect upon thymus-dependent lymphocytes but may elicit inhibitory effects mediated by adherent spleen cells (macrophages and/or sticky bursa-dependent lymphocytes) that have also been stimulated by antigen.

1

Supported by American Cancer Society Grant IC-72 and USPHS Grant CA 13105.

This content is only available via PDF.